|
UR8000 Coagulation Analyzer – High-Throughput Automated Hemostasis Testing System
For a central lab processing hundreds of coagulation panels daily, the bottleneck is rarely the reagent — it’s the instrument’s ability to maintain accuracy under load. The UR8000 represents a Chinese manufacturer’s entry point into that high-stakes segment.
The UR8000 is a fully automated hemostasis testing system built for laboratories where volume is relentless. Rated at 900 tests per hour for core parameters like PT, APTT, FIB, and D-Dimer, it slots into high-throughput environments that do not tolerate lag or manual error.
Forty detection channels support three methodologies — coagulation, immunoturbidimetry, and chromogenic assays — on a single platform. This eliminates the need to split panels across instruments, a practical advantage for labs looking to consolidate workstations and reduce sample transit time.
The system automates what techs previously had to watch for: hemolysis, icterus, and lipemia are flagged pre-analysis, and reaction curve integrity is checked before results are reported. In a high-volume shift, that kind of preprocessing reduces repeat testing and frees skilled staff for interpretation.
Biosafety measures are structural rather than optional. Closed-tube sampling, automated barcode reading, and cap-piercing minimize contact with patient specimens. For labs still reliant on open-tube workflows, this represents a meaningful upgrade in both safety and traceability.
The UR8000 is designed to interface with laboratory automation systems. That positions it not as a standalone device but as a node in a larger logistics chain — where sample arrival, analysis, and result routing are coordinated by middleware rather than human decision.
China’s diagnostics manufacturing ecosystem now routinely offers throughput levels once reserved for European or Japanese platforms. The UR8000 is evidence that the gap in high-end hemostasis testing is closing — not through imitation, but through focused automation engineering.
For procurement managers evaluating total cost of ownership, the UR8000’s appeal lies less in headline speed than in the elimination of secondary handling: fewer manual checks, fewer interruptions, fewer instruments per square meter.
Why it matters:
For hospital networks and independent diagnostic chains in China, the UR8000 translates directly into reduced turnaround time per sample and lower operator fatigue. Its ability to run three assay types on one line also simplifies reagent supply chains and training requirements.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.